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TCR Specificity Dictates CD94/NKG2A
Expression by Human CTL
2000; R.J. Winchester et al., 2001, Arthritis Rheum., ab-
stract).
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The potential role of NKG2D and CD94/NKG2 and theirBarcelona 08003
Spain ligands in the regulation of intraepithelial CTL in normal
and diseased tissues has been recently suggested (Jabri
et al., 2000; Roberts et al., 2001). By sensing local stress
and inflammation through altered levels of their MHCSummary
class I and MHC class I-like ligands, they may locally
up- or downregulate the adaptive CTL response.Activating and inhibitory CD94/NKG2 receptors regu-
The expression of such receptors on memory/effectorlate CTL responses by altering TCR signaling, thus
CTL raises several important, unanswered questions. Ismodifying antigen activation thresholds set during thy-
expression of a given activating or inhibitory NKR amic selection. To determine whether their expression
clonal attribute; i.e., is it uniform within the progeny ofwas linked to TCR specificity, we examined the TCR
a T cell clone or is it stochastically determined? Is NKRrepertoire of oligoclonal CTL expansions found in hu-
expression stable or is it a function of the activationman blood and tissues. High-resolution TCR repertoire
status? How is the expression of different isotypes of theanalysis revealed that commitment to inhibitory
same NKR family, which have the same ligand specificityNKG2A expression was a clonal attribute develop-
but opposing activating and inhibiting functions, regu-mentally acquired after TCR expression and during
lated at the clonal level? Given that T cells undergoantigen encounter, whereas actual surface expression
negative selection during thymic development based ondepended on recent TCR engagement. Further, CTL
TCR signaling by MHC/self-peptide complexes in theclones expressing sequence-related TCR, and there-
absence of NKR, expression of NKR at the memory/fore sharing the same antigen specificity, invariably
effector stage in the periphery is predicted to profoundlyshared the same NKG2A commitment. These findings
alter the activation thresholds set in the thymus and maysuggest that TCR antigenic specificity dictates NKG2A
thus promote or prevent immunopathological responsescommitment, which critically regulates subsequent
and autoimmunity (Lanier and Phillips, 1996). Such con-activation of CTL.
siderations suggest that expression of NKR might be
tightly regulated and coordinated with individual TCR
Introduction specificities.
Some of these issues have also been raised for NK
The innate immune response to signals triggered by cells, but, in the absence of clonal markers, the develop-
pathogens and necrotic cell products plays a critical mental regulation of NKR expression and the integration
role in the activation of naive T cells (Matzinger, 1994; of their combined signaling remain poorly understood
Medzhitov and Janeway, 2000; Steinman et al., 2000). (Colonna et al., 2000; Long et al., 1997; Raulet et al.,
The activation and survival of memory/effector CTL can 2001; Schatzle et al., 1999; Smith et al., 2000). In fact,
also be regulated by innate signals, through a set of because T cells express a well-defined clonal marker,
inhibitory and activating NKR which critically modulate the TCR, which is also the dominant activating signaling
the ability to clear viruses and reject tumors in vivo force, these issues might be easier to address in T cells
(Bellon et al., 1999; Groh et al., 2001; Lanier and Phillips, than in NK cells. Furthermore, because natural expan-
1996; Moser et al., 2002; Roberts et al., 2001; Speiser sions of memory/effector T cells driven by the same
et al., 1999; Ugolini and Vivier, 2001; Zajac et al., 1999). antigen often share structural similarities in their TCR,
NKR might also be implicated in autoimmune T cell- as detected by spectratyping and sequencing (Bourcier
mediated injury (Jabri et al., 2000; Namekawa et al., et al., 2001; McHeyzer-Williams et al., 1999), it is possible
to identify at least some of the CTL clones driven by the
same antigen without precise knowledge of this antigen5 Correspondence: bjabri@bsd.uchicago.edu
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(Arstila et al., 1999; Casanova and Maryanski, 1993; Cos- more, the data indicate that NKG2A is selectively pres-
ent in the subpopulation of CD94High T-IEL and T-PBL,tello et al., 2001; Yang et al., 1996).
Here, we examined the expression of the inhibitory whereas the activating NKG2C and E/H isotypes, or at
least their transcripts, are broadly expressed.CD94/NKG2A receptor and its relationship with TCR
clonotypic specificity in fresh human CTL using large-
scale, high-resolution analysis of their clonotypic reper- CD94 Receptors in CD94HighNKG2A
toire. We identified and studied multiple naturally ex- and CD94LowNKG2A CTL Have
panded CTL clones in vivo in the intestinal tissue, as Functionally Opposite Properties
well as in the blood. We found that expression of CD94/ Using a redirected lysis assay (Perez-Villar et al., 1995),
NKG2A was a clonal attribute identifying memory/ we examined the effect of co-crosslinking CD94 with
effector CTL with an entirely distinct TCR repertoire. the TCR. In these experiments, an anti-MHC class I mAb
Further, CTL clones expressing distinct but sequence- served as control. Crosslinking CD94 alone on CD3
related TCR, thus presumably of identical antigen speci- CD94 T-IEL cell lines did not induce target lysis (Figure
ficity, invariably shared the same NKG2A pattern. Finally, 1D), whereas, in control experiments with NK cells ex-
our study revealed that NKG2A participates in a negative pressing CD94LowNKG2A receptors purified from pe-
feedback loop in which TCR stimulation upregulates ripheral blood, this treatment induced specific target
NKG2A expression, and in turn, NKG2A downmodulates cell lysis (data not shown). However, in TCR/CD94 co-
TCR activation. stimulation experiments, crosslinking CD94 markedly
enhanced TCR-mediated cytolysis in the CD94LowN-
KG2A (NKG2C,E/H) cell lines. In contrast, it inhibitedResults
TCR-mediated cytolysis in the CD94HighNKG2A cell
lines and had no effect on a cell line expressing CD94CD94 and NKG2 Isotype Expression Defines
homodimers (NKG2A,C,E/H) (Figure 1D). Similar resultsDistinct Subsets in CTL
were obtained with multiple IEL lines and clones ex-As previously reported, 30%–45% of intestinal intraepi-
pressing NKG2C/E/H or NKG2A. These findings suggestthelial T lymphocytes (T-IEL) expressed CD94, 90%
that CD94 T-IEL can be subdivided into three function-of which were CD8TCR (Jabri et al., 2000). Analysis
ally distinct subsets based on the expression of inhibi-of 15 freshly isolated T-IEL preparations using anti
tory CD94HighNKG2A receptors, activating CD94LowTCR, CD94, and NKG2A mAbs revealed two major
NKG2C/E receptors, or nonfunctional CD94 homodi-populations of CD94 TCR IEL according to the ex-
mers. Because CD94 engagement in clones expressingpression of NKG2A (Figure 1A). The NKG2A cells repre-
both inhibitory NKG2A and activating NKG2C, E resultedsented on average 40% (range 25%–75%) of the CD94
in TCR inhibition, the inhibitory phenotype appears topopulation and, as for NK cells (Perez-Villar et al., 1995),
be dominant (data not shown).they expressed a higher level of CD94 (CD94High) than
the NKG2A cells (CD94Low). In PBL, 8%–18% of CD3T
cells expressed CD94 receptors (Jabri et al., 2000), Distinct Oligoclonal TCR Repertoires
in CD94HighNKG2A and CD94LowNKG2A CTL30%–80% of which were NKG2A.
Because mAbs specific for the activating NKG2 iso- Taking advantage of the presence of large oligoclonal
expansions of memory/effector CTL among T-IEL, wetypes are currently not available, we examined mRNA
expression by PCR on freshly purified CD94, CD94High compared the TCR repertoire of the functionally distinct
CD94/NKG2 subsets. The IEL preparations obtainedNKG2A, and CD94LowNKG2A subsets of TCR IEL
and PBL (Figure 1B) and in clones derived from these from 15 different individuals were four-color stained for
 TCR, CD94, NKG2A, and each available BV family.subsets (Figure 1C). The NKG2A transcripts were selec-
tively expressed in the CD94HighNKG2A population and The  TCR repertoires of most individuals were domi-
nated by a few markedly enlarged BV families, whichnot detectable in the CD94Low or CD94 subset, whereas
the activating isotypes NKG2C, NKG2E, and its splicing often differed between individuals (Figure 2A). Impor-
tantly, the predominant BV families in the CD94Highform NKG2H were expressed in all subsets. All CD94High
NKG2A clones expressed NKG2A, and many also ex- NKG2A cells largely differed from that of the CD94Low
NKG2A cells. For example, in IEL sample H, BV7 waspressed NKG2C (98%–100%) and E/H (50%–90%) tran-
scripts, in agreement with results obtained with fresh expressed by 17% of the CD94LowNKG2A cells but only
1.3% of the CD94HighNKG2A cells. Conversely, in sam-populations. In contrast, none of the 19 IEL and 24 PBL
CD94LowNKG2A clones obtained from three healthy in- ple E, BV7 was expressed by 20% of the CD94High
NKG2A cells and barely detectable in the CD94Lowdividuals expressed detectable levels of NKG2A,
whereas 78%–90% contained NKG2C and/or NKG2E NKG2A cells. Interestingly, the BV3 family, which was
found to be a major family in several (5 of 15) individuals,transcripts. The remaining clones lacked any detectable
transcripts for NKG2A, C, E, or H, suggesting that they as reported by others (Blumberg et al., 1993; Van Kerck-
hove et al., 1992), always predominated in the NKG2Aexpressed CD94 homodimers. This finding was further
confirmed at the protein level by CD94 coimmuno- subset (Figure 2A).
Next, we performed a higher resolution analysis ofprecipitation experiments of 35S-labeled cells (data not
shown). Altogether, these results suggest that the the TCR repertoire by determining the CDR3  chain
length distribution. This analysis demonstrated that theCD94LowNKG2A population is composed of a major
subset defined by the expression of activating CD94/ clonal composition of the CD94HighNKG2A and CD94Low
NKG2A repertoires differed markedly from one an-NKG2C, E/H heterodimers, and a minor population ex-
pressing nonfunctional CD94 homodimers. Further- other. Figure 2B contains a representative example from
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Figure 1. Functional Subsets of CD94
Memory/Effector CTL According to NKG2
Isotype Expression
(A) Freshly isolated IEL and PBL were stained
with anti-TCR, anti-CD8, anti-CD94, and
anti-NKG2A antibodies to sort CD8TCR
with a CD94HighNKG2A, CD94LowNKG2A, or
CD94 phenotype. Statistical quadrants were
set based on isotype control staining (data
not shown).
(B and C) The pattern of NKG2 isotype ex-
pression defined by RT-PCR with NKG2 iso-
type-specific primers is shown in (B) freshly
sorted T-IEL subsets and (C) CD94High
NKG2A and CD94HighNKG2A clones directly
derived from the corresponding purified IEL
and PBL subsets.
(D) The function of CD94 receptors was stud-
ied in subsets expressing CD94HighNKG2A,
CD94LowNKG2A, and CD94/CD94 homodi-
mers using a redirected cytolytic assay of
P815 cells in the presence of various doses
(10–20 ng/ml) anti-CD3 and 1 g/ml of anti-
CD94 mAb or isotype control (anti-MHC class
I mAb).
IEL sample D showing that a single BV12 expansion of found to be composed of major oligoclonal expansions
that differed between the two populations by flow cy-CDR3 length  11 was present in the CD94LowNKG2A
subset, whereas reciprocally a BV18 expansion of CDR3 tometry (Figure 2A) andchain length distribution analy-
sis (Figure 2B).length  11 was exclusively detected in the CD94High
NKG2A cells. Likewise, the BV repertoire of the CD94High Using the polyclonal CD4 PBL repertoire as a refer-
ence, we measured a marked degree of oligoclonal nar-NKG2A and CD94LowNKG2A subsets of PBL were also
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rowing in these CD94 cells, often reduced to one or sets were FACS-sorted from cell lines derived from fresh
CD94HighNKG2A and CD94LowNKG2A IEL. Sequencingtwo expansions for some BV families, with a number
of BV families lacking detectable representation in the and CDR3 length distribution analysis revealed a single
AV19  chain of CDR3 length  11: ALSEAYVGKLI inrepertoire. On average, 16 oligoclonal expansions were
found among all 23 BV families in the CD94HighNKG2A both populations, demonstrating a single, massively ex-
panded BV2 IEL clone with heterogeneous surface ex-and CD94LowNKG2A IEL subsets (Figure 2C). Nearly
all of the repertoire was contained in these oligoclonal pression of NKG2A.
expansions, as expected in a population selected for
memory/effector functions. Importantly, the large major- NKG2A Commitment of CTL Clones
ity of these oligoclonal expansions typically differed be- We reasoned that these instances of intraclonal hetero-
tween the two CD94 populations, suggesting a link be- geneity for NKG2A expression could reflect stochastic
tween TCR and NKG2 isotype usage. Using a statistical commitment by individual members of some clones or,
measure of the dissimilarity of two repertoire distribu- alternatively, could result from variable levels of induc-
tions, the Hamming distance (HD), which ranges from 0 tion within clonally committed populations. By combin-
for identical populations to 100 if there is no overlap, ing three different approaches, we demonstrated clonal
we found that the CD94HighNKG2A and CD94LowNKG2A commitment and showed that NKG2A could be induced
subsets were nearly as different from one another (HD in the NKG2A-negative members of NKG2A-positive
45) than from the reference panel of polyclonal CD4 clones. Further, we showed that these NKG2A-negative,
PBL (HD  60 and 63, respectively). NKG2A-committed cells expressed CD94 homodimers.
First, clones with heterogeneous NKG2A expression
were investigated. In 3/3 cases studied, the NKG2A neg-Heterogeneous Expression of NKG2A
in a Few CTL Clones ative members of these clones were found to induce
NKG2A upon TCR stimulation in vitro, as shown in FigureIn apparent exception with the general rule established
above, in a small number of cases, the  chain length 3A for the AV19BV2 clone previously identified in Figures
2A and 2B. In this experiment, NKG2A AV19BV2 cellsdistribution suggested the presence of shared oligoclo-
nal expansions between the two subsets (Figure 2). In were sorted from the CD94LowNKG2A IEL sample C, and
upon stimulation by anti-CD3, 60% induced surfacePBL sample P, a BV5 oligoclonal expansion of CDR3
length 11 was found in both the CD94HighNKG2A and NKG2A by day 10 in a time-dependent progressive man-
ner. NKG2A mRNA, which was undetectable in the start-CD94LowNKG2A subsets. In IEL sample C, the large
shared BV2 subset identified by flow cytometry (Figure ing NKG2A population, was strongly induced as well.
Further, NKG2A expression progressively decayed upon2A) consisted of a similar oligoclonal expansion with a
 chain CDR3 length  10 in both the CD94HighNKG2A removal from the CD3-coated wells and resting, sug-
gesting that sustained TCR stimulation is necessary toand CD94LowNKG2A subsets (Figure 2B). A general
analysis across all BV families of four IEL samples sug- maintain the expression of NKG2A. Neither IL-15 nor IL-
12 alone could induce NKG2A expression, although IL-gested that up to 21% of the oligoclonally expanded
repertoire might be shared between the CD94High 15 did induce CD94 in CD94-negative IEL (Jabri et al.,
2000, and data not shown). Identical results were ob-NKG2A and the CD94LowNKG2A cells (Figure 2C). In
one case (sample N), up to half the expansions were tained with another oligoclonal expansion, BV16, which
was also heterogeneous for NKG2A (data not shown).potentially shared (Figure 2C). These findings suggested
that some degree of heterogeneity in NKG2A expression Interestingly, the proportion of cells in the different
CD94LowNKG2A IEL subsets that could be induced tomight exist within some clonal expansions.
This was further examined by bulk sequencing of express NKG2A upon TCR stimulation roughly corre-
sponded to the proportion of cells present in thethese BV expansions. Sequencing of BV2 of CDR3
length 10 in the CD94HighNKG2A and CD94LowNKG2A CD94LowNKG2A that were shared with the CD94High
NKG2A subset. For example, in Figure 3B, the extentsubsets of sample C (Figure 2) revealed identical V
chain sequences: STSGSSYEQY. To determine the na- of NKG2A induction in the CD94LowNKG2A cell lines C
and N (20 and 40%, respectively) paralleled the fre-ture of the  chains associated with this  chain, the
BV2CD94HighNKG2A and BV2CD94LowNKG2A sub- quency of clones shared with the CD94HighNKG2A pop-
Figure 2. Clonal Composition of CD94HighNKG2A and CD94LowNKG2A Subsets of IEL and PBL
(A) Freshly isolated IEL and PBL were stained with anti-CD8, anti-CD94, anti-NKG2A, and a panel of anti-TCR BV family-specific antibodies
to define BV usage in CD94HighNKG2A and CD94LowNKG2A subsets. All predominant BV families representing 5% or more of the cells are
shown.
(B) TCR  chain CDR3 length distribution in freshly isolated CD94HighNKG2A and CD94LowNKG2A IEL and PBL. Representative examples
illustrate the oligoclonal nature of the TCR repertoires in IEL and PBL. Peaks corresponding to BV12 in IEL and BV13 and BV5 (CDR3 length
10) in PBL were almost exclusively present in the CD94LowNKG2A population. Conversely, BV18 in IEL and BV6 in PBL were almost exclusively
present in the CD94HighNKG2Apopulation. In contrast, the BV2 peak in IEL and the BV5 (CDR3 length 11) in PBL were present in both the
CD94LowNKG2A and the CD94HighNKG2A subsets. BV12 and BV18 IEL peaks correspond to sample D in (A), BV2 in IEL corresponds to
sample C, and all PBL peaks correspond to sample P.
(C) Summary of the number of oligoclonal expansions found in all BV families in each sample according to their presence in the CD94LowNKG2A
or CD94HighNKG2A subset. The Hamming distances (HD) were calculated to compare the repertoires of the CD94LowNKG2A, the CD94High
NKG2A, and the reference CD4 PBL populations for all BV families in all samples studied. HD values range from 0 for identical subsets to
100 for strictly distinct subsets.
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Figure 3. NKG2A Commitment Revealed by TCR Engagement
(A) The CD94LowNKG2A subset of the V2 IEL oligoclonal expansion in sample C (shown to be heterogeneous for NKG2A expression in
Figures 2A and 2B) was purified and stimulated by anti-CD3. Cell surface NKG2A expression progressively increased until d10 when cells
were harvested and rested in the absence of anti-CD3. At d40, NKG2A expression was barely detectable. NKG2A transcripts absent at d0
were induced at d5.
(B) Anti-CD3 stimulation was performed to measure the proportion of NKG2A-inducible cells among the CD94LowNKG2A subsets of samples
C and N.
(C) Anti-CD3 stimulated clones expressing CD94 homodimers (CD94LowNKG2), but not clones expressing activating CD94/NKG2C,E receptors,
were induced to express NKG2A.
ulation (18 and 50%, respectively, in Figure 2C). Taken lation (Figure 4). For example, the BV4 clone with the
CDR3 motif PGGRAYNSPLH and the BV3 clonetogether, these findings supported the notion that mem-
bers of the same clone shared the same NKG2A commit- SPPGLAGNNEQF present in the initial CD94HighNKG2A
and CD94LowNKG2A IEL subsets were also found in thement, even though in some cases NKG2A expression
appeared heterogeneous. induced NKG2A subset. Remarkably, while these clones
represented less than one-third of the initial CD94LowSecond, we analyzed the overall population of
CD94LowNKG2A cells that could be induced to express NKG2A IEL subset, they became dominant in the
NKG2A-induced subset. This induction was specific be-NKG2A upon TCR activation and compared it to the
initial CD94HighNKG2A and CD94LowNKG2A IEL sub- cause none of the other 21 clones found in the CD94Low
NKG2A population were induced to express NKG2A,sets. For this study, CD94LowNKG2A cells were stimu-
lated with anti-CD3 for 3–4 days, and the NKG2A even though their representation was at least 6- to 10-
fold greater than the induced clones. In repeated experi-(termed NKG2A-induced) cells were sorted for TCR anal-
ysis.  chain length distribution and sequencing indi- ments, the TCR repertoire of the NKG2A-induced cells
was highly reproducible. Similar results were obtainedcated that, in all cases where clones were shared
between CD94HighNKG2A and CD94LowNKG2A IEL sub- for 6/6 different BV families (not shown). Under this anti-
CD3 stimulation protocol, the stimulation of NKG2Acellsets, they were also found in the NKG2A-induced popu-
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Figure 4. Clonal Patterns of NKG2A Expression and Induction in Precommitted Cells
The BV4 and BV3 repertoires ( chain length distribution and sequencing) of the CD94LowNKG2A cells induced to express NKG2A (“NKG2A-
induced” sorted 3 days after stimulation with anti-CD3) is shown in (C) for comparison with the repertoires of the original, freshly isolated
CD94HighNKG2A and CD94LowNKG2A subsets shown in (A) and (B).
lines such as the one shown in Figure 3B was polyclonal NKG2A was rapidly and disproportionately induced in
a select group of V, ruling out preferential growth ofbecause no significant changes in the V distribution
were observed. However, we consistently observed that rare, contaminant NKG2A cells (data not shown). We
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also observed rare examples of clones which were only et al., 2001; Yang et al., 1996). We therefore performed
plasmid and cell cloning and sequenced multiple andfound in the CD94LowNKG2A subset but could induce
chain CDR3 regions found within the same spectratypicNKG2A upon TCR stimulation, such as the BV3 se-
bands or oligoclonal expansions, because they wouldquence SVQGRGVTIY (Figures 4B and 4C), suggesting
be expected to contain such antigen-driven expansions.that these clones had not been recently activated
Sequence analysis of CD94HighNKG2A oligoclonalthrough their TCR in vivo.
expansions with the same CDR3 length revealed thatThird, all the CD94LowNKG2A clones that were shared
they were indeed composed of distinct sets of cloneswith the CD94HighNKG2A subset lacked detectable
with different nucleotide sequences characteristic of an-NKG2 C or E/H transcripts, suggesting that they ex-
tigen drive. Four features of antigen drive are illustratedpressed CD94 homodimers. For example, the BV2AV12
in Figures 4 and 5:and the BV16AV2 CD94LowNKG2A cells described
First, the conserved CDR3 length of expanded clonesabove that could be NKG2A induced lacked NKG2A, C,
with the same BV and TRBJ usage (e.g., 4/4 BV9 clonesand E/H transcripts and instead expressed nonfunc-
with CDR3 length 9 have the same TRBJ element 2-7*01;tional CD94 receptors (Figure 1D, right panel). In con-
3/4 BV16 clones with CDR3 length 10 have the sametrast, the NKG2A cells that remained NKG2A negative
TRBJ element 1-2*01).upon TCR engagement expressed functional activating
Second, multiple examples of nongermline-encodedCD94/NKG2C or E/H receptors (data not shown). These
CDR3 sequences were found to be conserved at theresults suggested that cells expressing CD94 homodi-
amino acid level but degeneratively encoded at the nu-mers were precommitted to NKG2A expression. To test
cleotide level, implying that the TCR were selected atthis hypothesis, clones expressing CD94 homodimers
the amino acid level (e.g., in Figure 4: the first four aminoidentified during systematic cloning of CD94LowNKG2A
acids of the related PGGRGYNSTPSH and PGGRAYNsubsets were tested for their ability to induce NKG2A
SPLH sequences are nongermline encoded; in Figureupon TCR stimulation. These cells represented 15%–
5: for the BV9 sequences, E in position 3 of clone 4, S20% of the CD94LowNKG2A subset (Figure 1C), a pro-
in position 5 of clone 2, D in position 3, and G-P inportion that correlated well with both the overall percent-
position 5-6 of clones 5 and 6 are instances of aminoage of shared clones (see Figure 2C) and the percentage
acid conservation; for the BV16 sequences, Q in positionof NKG2A-inducible cells within the CD94LowNKG2A
2 of clone 1, V in position 3 of clones 1 and 2, I in positionsubset (see Figure 3B). Figure 3C shows a representative
5 of clones 1 and 3, and D in position 5 of clones 4 andexample of the 4/4 clones expressing CD94 homodimers
5 are also instances of amino acid conservation). Thethat could be induced to express NKG2A. Further, the
pattern of conservation of amino acids correspondinginduction of NKG2A was followed by that of activating
to positions 97, 98, and 100 of  chain, as shown forNKG2 isoform transcripts, in accordance with our find-
the BV16 oligoclonal expansion in Figure 5, was also aing that most NKG2A clones also express activating
feature of T cell clonal selection by antigen (Bourcier etNKG2 transcripts. In the presence of NKG2A, these acti-
al., 2001; McHeyzer-Williams et al., 1999).vating isoforms should be prevented to costimulate TCR
Third, to formally establish that the five BV16 clonesactivation. In contrast, NKG2A could not be induced in
were driven by the same antigen, we showed that they40/40 clones expressing functional activating NKG2C,
had homologous  chains as well (Figure 5B). We sortedE/H receptors (see one example in Figure 3C). Thus,
the BV16-positive T cells from the sample C cell line,the component of the CD94LowNKG2A population which
cloned them, and determined the TCR sequencesexpresses CD94 homodimers (NKG2C, E/H negative)
of 17 individual T cell clones. Five clonal groups wereappears to be largely, perhaps entirely, NKG2A commit-
identified.  chain sequencing retrieved three of theted and poised to express NKG2A on the surface upon
same BV16 sequences as previously found in the freshTCR stimulation.
population, demonstrating that the clones analyzed
Taken together, these results establish that the TCR
were representative of fresh BV16 CD94HighNKG2Apop-
repertoires of CD94HighNKG2A and CD94LowNKG2A
ulation. The two remaining minor clonal groups had the
memory/effector CTL are essentially distinct. The appar- same CDR3 length  10 and shared the degeneratively
ent intraclonal heterogeneity with respect to NKG2A ex- encoded amino acid motif SxxG, further supporting the
pression within some clones corresponds to cells that presence of antigen drive. Strikingly, the  chains exhib-
are NKG2A precommitted but require TCR restimulation ited the same features typical of antigen drive as the 
for NKG2A reinduction. chains. Thus, all five clonal groups shared the same
AV12, the same CDR3 length of 9, and a common 4
CTL Clones Expressing Distinct but Sequence- amino acid motif CVVR (Figure 5B). Furthermore, the
Related TCR Share the Same NKG2A Commitment third and fourth position in this motif were degenera-
We next wanted to determine whether natural CTL tively encoded by, respectively, two and four different
clones expanded by the same antigen in vivo would nucleotide sequences, implying that the homologous 
share the same NKG2A commitment. Multiple studies chains had been selected at the protein level by the
have described the features that characterize the CDR3 same peptide. The conclusion that CTL expressing
region of antigen-expanded T cells in mice and humans these TCR were not a random set of cells but rather were
(Bourcier et al., 2001; Kalams et al., 1994; McHeyzer- driven by the same antigen, is based on the following
Williams et al., 1999; Sant’Angelo et al., 1997). These considerations. Assuming that AV family usage is ran-
features often allow the identification of T cells driven dom, the probability that 5/5 BV16  chains are associ-
by the same antigen, even in the absence of knowledge ated with the same AV is: (1/46)5, where 46 is the number
of AV families. This probability should be multiplied byof the antigen (Casanova and Maryanski, 1993; Costello
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Figure 5. CTL Clones Expressing Sequence-Related TCR Exhibit the Same NKG2A Expression Pattern
(A) Analysis using  chain length distribution and sequencing of two BV9 oligoclonal expansions of CDR3 length  9 and 11 shows that each
oligoclonal expansion is composed of a group of related sequences. Bolded amino acid residues indicate differences from the reference
sequence. The lower portion of the figure contains the nucleotide sequence showing differences in the use of somatic and germline elements.
Germline origin is indicated in uppercase, with the D element in bolded italics. Somatic origin is shown in lowercase.
(B)  chain sequence analysis of an isolated BV16 oligoclonal expansion of CDR3 length  10 in freshly purified T cells reveals that the
oligoclonal expansion is composed of five related clones. To determine the  chain pairing of these clones, the BV16 positive T cells were
subcloned and the TCR sequences of 17 individual subclones are shown.
the likelihood of selecting five chains of the same CDR This calculation assumes no pairing bias between AV2
and BV16, which is supported by published studies3 length of 9. Assuming 11 to be the median length
of the distribution, this is approximately (1/10)5. This (Mackensen et al., 1994; Pietra et al., 2001). Thus, the
finding that 5/5 different clones with structurally homolo-infinitesimal probability of selecting this combination of
structurally similar  chains by chance (1013) would gous  chains and  chains shared the same NKG2A
commitment further strengthens the conclusion alreadybe further reduced if the probability to express the con-
served nongermline-encoded CVVR motif was included. drawn from the extensive TCR  chain repertoire analy-
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Figure 6. Model for NKG2A Expression and
Function in Effector/Memory CTL
(A) Naturally expanded CTL clones express-
ing related TCR (likely sharing the same anti-
gen specificity) share the same commitment
to express NKG2A. Thus, the context in which
antigen-specific T cells are primed or ex-
panded during the differentiation process
into CD8 effector/memory cells (e.g., the na-
ture of the APC presenting the antigen or the
persistent nature of the antigen) determines
NKG2A commitment.
(B) NKG2A/TCR dominant-negative circuit
loop in effector CTL. Surface expression of
NKG2A is dependent on TCR stimulation at
the effector stage. Resting effector CTL pre-
committed to the expression of NKG2A ex-
press nonfunctional CD94 homodimers.
Upon TCR triggering, they express surface
CD94/NKG2A. In turn, CD94/NKG2A exerts a
negative feedback signal on TCR activation,
if it encounters the appropriate HLA-E ligand.
This negative feedback may be an important
mechanism to prevent chronic inflammation
and autoimmunity in an environment of high
antigenic load such as the intestine.
sis in 15 individuals, that TCR specificity for antigen where a fraction or even the majority of a CTL clone
dictates commitment to NKG2A expression. This con- lacked NKG2A, an apparent exception to the clonal rule,
clusion implies that NKG2A commitment is a postthymic TCR engagement promptly reinduced mRNA and pro-
differentiation event imparted at the clonal level upon tein expression, demonstrating stable commitment at
in vivo encounter with antigen. the clonal level. The NKG2A-inducible cells appeared
to express CD94 homodimers because they lacked de-
tectable mRNA for NKG2A, C, and E/H isotypes andDiscussion
because CD94 engagement did not modulate TCR acti-
vation. In contrast, NKG2A could not be induced inBy examining memory/effector CTL in humans where
NKG2A clones expressing activating CD94/NKG2 re-a NKG2A-specific mAb is available, we exploited the
ceptors. We propose a scenario whereby the subset ofpresence of a clonal marker, the  TCR, and the exis-
CTL clones that are committed to NKG2A expressiontence of naturally expanded clones in the blood and
maintain or upregulate NKG2A upon TCR engagement.intestinal tissue to examine the regulation of NKG2 iso-
This in turn exerts a negative feed-back on TCR activa-types at the clonal level and with respect to TCR speci-
tion, with subsequent decay in NKG2A expression andficity. We studied CD94HighNKG2A and CD94LowNKG2A
return to a state where TCR activation is heightenedmemory/effector subsets freshly purified ex vivo from
(Figure 6B). Such regulation, which has not been ob-15 individuals, as well as corresponding cell lines and
served for other inhibitory NKR such as KIR (Vely et al.,clones derived in vitro, combining functional studies and
2001), is reminiscent of the CTLA-4/B7 regulatory loopextensive TCR repertoire analysis including determina-
(Perkins et al., 1996), but it has specific features adaptedtion of TCR/ pairing.
to the biology of memory/effector CTL, particularly inThe results demonstrate that, under natural condi-
tissues such as the intestinal epithelium. Indeed, CD94/tions, commitment to expression of the inhibitory
NKG2A and HLA-E but not CTLA-4/B7 are significantlyNKG2A isotype is a clonal attribute restricted to a subset
of memory/effector CTL expansions. In some cases expressed in the intestinal environment (Bloom et al.,
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1995; Jabri et al., 2000, and B.J., unpublished data). The of effector functions in vitro. Thus, NKG2A expression
advantage of such a scenario in a tissue environment appears to be a stable commitment of some memory/
of high antigenic load such as the intestine could be to effector CTL clones related to their antigen specificity
allow some CTL to respond initially maximally to anti- rather than a feature associated with a particular stage
gens, submitting them later on to a fine-tuning of their of their development. Most interestingly, commitment
TCR signaling threshold in order to downmodulate, for to NKG2A, when it occurs, seems to be a general feature
example, persisting immune reactions that might other- of all the identifiable CTL involved in the immune re-
wise lead to autoimmunity and chronic inflammation. sponse to a particular antigen rather than the attribute of
The flip side of this scenario is that, as recently sug- individual clones according to some unique properties,
gested for the mouse response to Polyoma virus, prema- such as high avidity for antigen. One possibility is that
ture shut-off of the CTL response, perhaps as a viral NKG2A commitment reflects the persistence of antigen,
immune evasion strategy, could facilitate viral persis- either in the form of continuous exposure to pathogen
tence and the emergence of virally induced tumors or of crossreactivity to a self-peptide. In this context,
(Moser et al., 2002). the presence of NKG2A could prevent clonal exhaustion
Oligoclonal expansions of memory/effector CTL ex- by terminal differentiation or suppress immunopatho-
pressing NKR have previously been detected in blood logical responses. Alternatively, the cytokine environ-
and tissues (Moretta and Moretta, 1997), but the link ment or the functional features of the activated APC
between TCR and NKR expression has been difficult to associated with specific contexts such as, for example,
ascertain in vivo. Studies of in vitro-derived human CTL viral infection, might induce NKG2A commitment.
clones found that members of the same clone could be Our study examined the natural range of TCR specific-
KIR or KIR and express different KIR patterns (Uhr- ities expressed in vivo by natural populations of mem-
berg et al., 2001; Vely et al., 2001), suggesting stochastic ory/effector CTL found in human tissues and blood. The
expression of these receptors during or after clonal findings do not allow the assignment of NKG2A induc-
expansion. Our study in the NKG2A system supports tion to specific immune situations, but they do predict
and extends the notion that NKR expression by CTL is that different immune conditions will result in different
developmentally a post-TCR phenomenon. However, in patterns of NKG2A induction (Figure 6A). In that respect,
marked contrast with the KIR studies, our data demon- a recent report suggested that a majority of mouse CTL
strate that NKG2A commitment is not stochastic but is specific for the dominant polyoma virus peptide antigen
uniformly imparted to the clonal progeny. Most impor- expressed an inhibitory NKG2 isotype, suggesting that
tantly with respect to the regulation of antigen-specific at least some viral conditions may be associated with
CTL responses, NKG2A commitment appears to be dic- such NKG2A induction (Moser et al., 2002). Together
tated by TCR specificity. First, the TCR repertoire of cells with other recent reports (Speiser et al., 1999; Ugolini
precommitted to the expression of inhibitory NKG2A and and Vivier, 2001), these results support therefore a fun-
those expressing only activating CD94/NKG2 receptors damental role of innate immunity receptors in controlling
are strictly distinct. Second, our extensive TCR reper- CTL activation and shaping the memory TCR repertoire.
toire analysis, which included several / chain pairing Further studies will be needed to elucidate the condi-
assignments, permitted the unambiguous identification tions leading to NKG2A induction in memory/effector
of multiple examples of clonal expansions expressing CTL and their relevance to the control of immune re-
related but nonidentical TCR. The role of antigen drive sponses in healthy and diseased tissues.
was evident in many cases due to the presence of de-
generatively encoded, identical amino acid motifs, or Experimental Procedures
highly conservative amino acid substitutions, whereas
mAbs and Cytokinesit was logically inferred in other cases with more pro-
Fluorochrome-conjugated mAbs against CD3, CD8, TCR, andnounced amino acid changes, by the usage of the same
CD94, unconjugated mAbs against CD3 (UCTH1, IgG1), and CD94BV, JV element, the same CDR3 length, and the pairing
(HP-3D9, IgG1), and isotype controls were purchased from Phar-with similar  chains. Thus, the combined results sug-
Mingen (San Diego, CA). Unconjugated anti-human MHC class I
gest that each of these clones recognizes the same or ABC B9.12.1 (IgG2a), unconjugated and PE-conjugated anti-CD94
a similar peptide. In this context, a major finding is that all mAb HP-3B1 (IgG2a), PE-conjugated anti-NKG2A Z199 mAb
the identifiable member clones comprising an antigen- (IgG2b), and FITC- and -PE conjugated mAbs directed against the
different TCR BV families were from Coulter-Immunotech (Miami,driven response consistently shared the same commit-
FL). Recombinant IL-15, IL-7, IL-12, IFN	, TNF-, IL-10, TGF, andment to NKG2A. This finding suggests that only particu-
IL-2 were from PharMingen.lar antigens and/or particular conditions of antigenic
stimulation lead to NKG2A commitment. An alternative
Lymphocyte Isolation
explanation is that NKG2A commitment is a temporal IEL were purified from jejunal mucosa obtained from healthy individ-
marker of CTL clones that recently expanded through uals undergoing gastric bypass for morbid obesity as previously
the effector phase. However, we do not favor this view described (Taunk et al., 1992). PBL were isolated from whole blood
of healthy volunteers by Ficoll density gradient centrifugation (Amer-for the following reasons. First, fresh CD94HighNKG2A
sham Pharmacia Biotech) according to standard procedures.and CD94LowNKG2ACTL had a similar CD45ROCD69
CCR7 profile and they both exerted redirected cyto-
FACS Analysis and Purification of IEL and PBL Subsetstoxic activity, the hallmarks of effector CTL (data not
Cells (2 
 105) were incubated with directly conjugated antibodies
shown). Secondly, NKG2A CTL clones—with the nota- according to standard protocols. Fluorescence was analyzed on a
ble exception of the few NKG2A-committed ones ex- four-color FACSCALIBUR (Becton Dickinson), with statistical quad-
pressing CD94 homodimers—were totally refractory to rants set to score as negative 99% of control Ig isotype-stained
cells.NKG2A expression upon TCR stimulation and induction
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Freshly isolated IEL and PBL were labeled with anti-CD94, anti- 100
(cpm experimentalcpm spontaneous)/(cpm maximumcpm
spontaneous).NKG2A, anti-CD8, and anti-TCR mAbs to sort TCRCD8 IEL,
using a VANTAGE FACS (Becton Dickinson), into CD94highNKG2A
and CD94lowNKG2A subsets. Purified subsets were subdivided to Acknowledgments
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